Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $89.38 USD
Change Today +0.47 / 0.53%
Volume 116.4K
As of 8:10 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

heartware international inc (HTWR) Snapshot

Open
$88.70
Previous Close
$88.91
Day High
$90.10
Day Low
$88.46
52 Week High
05/1/14 - $97.60
52 Week Low
12/11/14 - $69.05
Market Cap
1.5B
Average Volume 10 Days
139.3K
EPS TTM
$-1.88
Shares Outstanding
17.2M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for HEARTWARE INTERNATIONAL INC (HTWR)

heartware international inc (HTWR) Related Businessweek News

No Related Businessweek News Found

heartware international inc (HTWR) Details

HeartWare International, Inc., a medical device company, designs, develops, manufactures, and markets miniaturized implantable heart pumps or ventricular assist devices (VAD) for the treatment of advanced heart failure in the United States, Germany, and internationally. It offers HeartWare Ventricular Assist System, which comprises a VAD or blood pump, patient accessories, and surgical tools designed to provide circulatory support for patients in the advanced stage of heart failure. The company is also developing the MVAD, a miniaturized blood pump intended for chronic heart failure patients; and SYNERGY Circulatory Support System, a partial support system designed to treat less sick, ambulatory, chronic heart failure patients who are not yet inotrope-dependent. The company markets its products directly to clinicians and medical facilities, as well as through medical device distributors. HeartWare International, Inc. is headquartered in Framingham, Massachusetts.

585 Employees
Last Reported Date: 03/2/15

heartware international inc (HTWR) Top Compensated Officers

Chief Executive Officer, President, Managing ...
Total Annual Compensation: $541.3K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $324.8K
Chief Scientific Officer and Executive Vice P...
Total Annual Compensation: $331.6K
Senior Vice President, General Counsel and Se...
Total Annual Compensation: $329.2K
Senior Vice President of Sales & Marketing
Total Annual Compensation: $300.6K
Compensation as of Fiscal Year 2013.

heartware international inc (HTWR) Key Developments

Heartware International Inc. Presents at Barclays Global Healthcare Conference, Mar-10-2015 08:00 AM

Heartware International Inc. Presents at Barclays Global Healthcare Conference, Mar-10-2015 08:00 AM. Venue: Loews Miami Beach Hotel, 1601 Collins Avenue, Miami, Florida, United States. Speakers: Douglas E. Godshall, Chief Executive Officer, President, Managing Director and Executive Director.

Heartware International Inc. Announces Unaudited Consolidated Financial Results for the Fourth Quarter and Full Year Ended December 31, 2014

Heartware International Inc. announced unaudited consolidated financial results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company announced revenue of $73,209,000 compared to $53,054,000 for the same period of 2013. Income from operations was $4,077,000 against loss from operations of $19,496,000 for the same period of last year. Loss before taxes was $1,019,000 against $21,422,000 for the same period of last year. Net loss was $916,000 or a $0.05 loss per basic and diluted share, compared to a $22,048,000 net loss, or a loss of $1.33 per basic and diluted share, in the fourth quarter of 2013. Non-GAAP adjusted net loss was $6,936,000 against $15,216,000 for the same period of last year. Non-GAAP adjusted net loss per basic and diluted share was $0.41 against $0.92 for the same period of last year. Non-GAAP net loss for the fourth quarter of 2014 was $6.9 million, or $0.41 per basic and diluted share, compared to a loss of $15.2 million, or $0.92 per basic and diluted share in the fourth quarter of 2013. For the year, the company announced revenue of $278,420,000 compared to $207,929,000 for the same period of 2013. Loss from operations was $124,000 against loss from operations of $47,546,000 for the same period of last year. Loss before taxes was $18,806,000 against $58,844,000 for the same period of last year. Net loss was $19,366,000 or a $1.14 loss per basic and diluted share, compared to a $59,311,000 net loss, or a loss of $3.69 per basic and diluted share, a year ago. Non-GAAP adjusted net loss was $34,576,000 against $51,917,000 for the same period of last year. Non-GAAP adjusted net loss per basic and diluted share was $2.03 against $3.23 for the same period of last year. Non-GAAP net loss for 2014 was $34.6 million, or $2.03 per basic and diluted share, compared to a loss of $51.9 million, or $3.23 per basic and diluted share, in 2013.

Heartware International Inc. Presents at Raymond James & Associates 36th Annual Institutional Investors Conference, Mar-03-2015 04:35 PM

Heartware International Inc. Presents at Raymond James & Associates 36th Annual Institutional Investors Conference, Mar-03-2015 04:35 PM. Venue: JW Marriott Grande Lakes, 4040 Central Florida Parkway, Orlando, FL 32837, United States. Speakers: Douglas E. Godshall, Chief Executive Officer, President, Managing Director and Executive Director.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HTWR:US $89.38 USD +0.47

HTWR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Getinge AB kr216.50 SEK +1.80
Sunshine Heart Inc $4.18 USD +0.05
Teleflex Inc $119.89 USD +0.74
Thoratec Corp $41.00 USD +0.96
View Industry Companies
 

Industry Analysis

HTWR

Industry Average

Valuation HTWR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 5.5x
Price/Book 7.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 4.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HEARTWARE INTERNATIONAL INC, please visit www.heartware.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.